Buy & Sell Hims and Hers Health Inc (HIMS) – Hims and Hers Health Inc Price Today
Aura AI Summary
Key Stats
- $7.86BMarket Cap
- HealthSector
- -28.12%3M Drawdown
- $8.24BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 12 daysTypical Hold Time
Hims and Hers Health Inc (HIMS) is currently valued at a market capitalization of $7.86B, with an enterprise value of $8.24B. Over the past 52 weeks, Hims and Hers Health Inc has traded between a low of $14.52 and a high of $66.18, highlighting its annual price range. Over the past three months, Hims and Hers Health Inc has recorded a drawdown of -28.12%, reflecting recent price volatility. On average, investors hold Hims and Hers Health Inc for approximately 12 days, indicating typical investor behavior on the platform.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Most Recent News
AI tech boom may surpass the internet bubble in scale and energy use, warns ex-CIA analyst.
Jim Rickards, a former CIA financial advisor, highlights that the current AI industry is consuming more capital and energy than the 1990s internet boom. With nearly $5 trillion expected to be spent on AI data centers in the U.S. alone, the AI buildou...

Five under-the-radar stocks gain attention for deals, partnerships, and potential short squeezes.
The Benzinga Stock Whisper Index highlights five stocks gaining investor interest: FreeCast for expanding DIRECTV and Starlink reseller deals despite financial concerns; American Airlines for launching Starlink on planes and multiple analyst price ta...

Wall Street sees Lucid stock rising 65% despite mixed reviews and execution risks
Wall Street analysts remain cautious but optimistic about Lucid Group's stock, with an average 12-month price target of $9.75, implying a 64.7% upside from its current $5.92 price. The consensus rating is 'Hold,' reflecting mixed views amid concerns ...
